U.S. Electrical Stock News

NYSE:ITGR
NYSE:ITGRMedical Equipment

Integer Holdings Review Tests Shareholder Value As Profitability Improves

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...
NasdaqGS:WABC
NasdaqGS:WABCBanks

A Look At Westamerica Bancorporation (WABC) Valuation After Expanded Buyback And Dividend Increase

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...
NasdaqGM:RMIX
NasdaqGM:RMIXBasic Materials

Suncrete Adds Industry Veterans To Board As Investors Weigh Share Pullback

Suncrete (NasdaqGM:RMIX) has appointed Charles Owens and Noreen Skelly as independent directors to its Board. Both Owens and Skelly have also joined the Audit Committee, with Skelly serving as Chair. The appointments expand the Board and Audit Committee with additional construction and banking sector expertise. Suncrete, trading at around $15.4, has seen its share price move 38.9% over the past 30 days and 35.1% year to date, with a 39.1% return over the past year and a 2.7% decline over...
NYSE:ONON
NYSE:ONONLuxury

On Holding Discounting Puts Premium Pricing And Growth Story Under Review

Emerging discounting on core On Holding products at key retailers and outlets has raised fresh questions about the strength of the NYSE:ONON premium brand. Channel checks highlight margin pressure in the wholesale channel, challenging recent messaging around full price discipline and margin expansion. The news follows the return of the co founders as co CEOs and arrives as investors reassess growth and profitability expectations. On Holding, trading at $34.59 under ticker NYSE:ONON, is...
NYSE:FAF
NYSE:FAFInsurance

Is It Too Late To Consider First American Financial (FAF) After Its 17% Monthly Surge?

Investors may be wondering if First American Financial at around US$68 per share still offers value, or if most of the easy gains are already on the table. The stock is up 17.4% over the last 30 days and 12.0% year to date, with a 15.6% return over the past year and a 31.1% return over three years. These changes can influence how the market is pricing its risks and opportunities. These moves are playing out against a backdrop of ongoing interest in US insurance stocks and property related...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial Labor Talks Test 2026 Guidance And Earnings Resilience

CNH Industrial (NYSE:CNH) is in active labor negotiations with nearly 300 UAW workers at its Racine, Wisconsin plant as their contract expires. The discussions follow a previous extended strike at the facility and there is currently no strike action in place. The talks are taking place while the company reports weak Q1 results, margin pressure, and historically low North American agricultural equipment demand. Management has reaffirmed its 2026 guidance, but labor uncertainty at Racine could...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Expands MASH Franchise With Precision RNAi License For ARO PNPLA3

Madrigal Pharmaceuticals (NasdaqGS:MDGL) has secured an exclusive worldwide license to ARO-PNPLA3, an RNAi therapy for MASH, from Arrowhead Pharmaceuticals. The program is in clinical development, with Phase 1 data indicating substantial liver fat reduction and a favorable safety profile in a genetically defined MASH population. The deal expands Madrigal's pipeline beyond Rezdiffra and adds a precision medicine angle to its MASH franchise. Madrigal Pharmaceuticals enters this agreement with...
NYSE:VSTS
NYSE:VSTSCommercial Services

Is It Time To Reconsider Vestis (VSTS) After Its Recent Spin Off Repricing?

This article examines whether Vestis is attractively priced or already fully valued and walks through key signals that can help frame the stock's current valuation. Vestis recently closed at US$9.27, with returns of 18.4% over 30 days and 40.9% year to date. Meanwhile, the 7 day return of 3.6% and 1 year return of 6.4% indicate that the stock has not moved in a straight line. Recent headlines around Vestis have focused on its position within the Commercial Services sector and how investors...
NasdaqGS:EMBC
NasdaqGS:EMBCMedical Equipment

Embecta (EMBC) Margin Expansion To 12.9% Tests Bearish Earnings Sustainability Narrative

Embecta (EMBC) opened 2026 with Q1 revenue of US$261.2 million and basic EPS of US$0.75, alongside trailing twelve month revenue of about US$1.1 billion and EPS of US$2.38. These figures sit against trailing earnings growth of 139.7% and revenue growth of 0.8% year over year. Over recent quarters the company has seen revenue move between US$259 million and US$295.5 million, while quarterly basic EPS has ranged from US$0.25 to US$0.78. Together this sets up a picture of improving net profit...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Is It Too Late To Consider MYR Group (MYRG) After A 206% One-Year Surge?

If you are wondering whether MYR Group at around US$468.54 is offering value after such a strong run, or if you are late to the story, this article focuses squarely on what the numbers say about the stock's price. The share price has moved sharply, with returns of 41.6% over the past week, 64.0% over the past month, 106.7% year to date and 206.4% over the past year, which has naturally sharpened interest in what is now priced in. Recent coverage has centered on MYR Group's role as a...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar Unveils Hybrid Europe Index Blending Public And Private Leaders

Morningstar (NasdaqGS:MORN) has launched the Europe Modern Market 50 Index, a hybrid benchmark tracking major public and high growth private companies in Europe. The index combines large listed equities with influential late stage, venture backed private firms to reflect their growing role in European equity markets. The product draws on Morningstar’s private markets data capabilities through its PitchBook subsidiary. For you as an investor, the launch highlights how Morningstar is leaning...
NYSE:RHLD
NYSE:RHLDProfessional Services

Resolute Holdings Management Acquisition Of Husky Reshapes Fee Growth Outlook

GPGI, the operating platform of Resolute Holdings Management (NYSE:RHLD), has acquired Husky. The deal adds another fee generating business to RHLD's platform and supports its earnings base. The acquisition is intended to support both organic expansion and further acquisitions for RHLD. Resolute Holdings Management, through its GPGI platform, focuses on building a recurring management fee base that can scale over time. The addition of Husky fits this model by broadening the pool of fee...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Apple Hospitality REIT (APLE) Q1 FFO Stability Tests Bearish Margin Narratives

Apple Hospitality REIT’s Q1 2026 Earnings Snapshot Apple Hospitality REIT (APLE) opened 2026 with Q1 Funds From Operations of US$76.5 million and trailing 12 month net profit margins of 12.4%, while the stock trades around US$13.61. Over the past reported quarters, revenue has moved from US$333.0 million in Q4 2024 to US$327.7 million in Q1 2025 and US$326.4 million in Q4 2025, alongside basic EPS readings between US$0.12 and US$0.27 and trailing 12 month FFO in the US$359.2 million range...
NYSE:PGR
NYSE:PGRInsurance

Progressive Expands UpPayment Program As Investors Weigh Homeowners Growth Potential

Progressive (NYSE:PGR) is expanding its UpPayment program to offer larger down payment assistance for first-time homebuyers. The initiative aims to support hundreds of eligible applicants as part of a broader push to make homeownership more accessible. The program expansion is positioned within Progressive's wider homeownership and community engagement efforts. Progressive, trading at around $197.74, is drawing attention not for its share price moves but for this new push into direct...
NasdaqCM:SATL
NasdaqCM:SATLAerospace & Defense

Satellogic Hires Industry Veterans As Sovereign Geo-Intelligence Strategy Meets Market Hype

Satellogic (NasdaqCM:SATL) has expanded its global sales organization with three senior industry veterans focused on sovereign geospatial intelligence customers. The hires are aimed at deepening relationships with defense and intelligence agencies and supporting the company's wider commercial push. For investors tracking NasdaqCM:SATL, these leadership additions come after the previously announced $12 million satellite transfer agreement and at a time when the stock is trading around $7.0...
NasdaqGS:YORW
NasdaqGS:YORWWater Utilities

York Water (YORW) Margin Slippage Tests Premium P/E Growth Narrative

York Water’s latest earnings snapshot York Water (YORW) has just posted another quarter of steady utility earnings, with Q4 2025 revenue at US$19.5 million and basic EPS of US$0.36, supported by trailing 12 month revenue of US$77.5 million and EPS of US$1.39. Over recent quarters the company has seen revenue range between US$18.5 million and US$20.4 million, with quarterly EPS between US$0.25 and US$0.43. The trailing net profit margin sits at 25.9% compared with 27.1% a year earlier, which...
NasdaqGM:STIM
NasdaqGM:STIMMedical Equipment

Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative

Neuronetics (STIM) has just put fresh numbers on the table for Q1 2026, and recent filings show quarterly revenue at US$41.8 million in Q4 2025 with a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$149.2 million and a basic EPS loss of US$0.59. Over recent quarters, the company has seen revenue move from US$18.5 million in Q3 2024 to US$22.5 million in Q4 2024 and then to US$42.8 million in Q4 2025, while quarterly basic EPS losses shifted from US$0.44 to US$0.35 and...
NYSE:CAVA
NYSE:CAVAHospitality

CAVA Glazed Salmon And Drive Thru Push Test High P/E Expectations

CAVA Group (NYSE:CAVA) is rolling out a new Glazed Salmon menu item across its U.S. restaurants. The company is also pushing into more suburban locations that include drive thru formats. These moves mark a meaningful shift in how CAVA approaches both its menu and store footprint. CAVA Group comes into these changes with its stock at $90.34 and a year to date return of 49.2%, after a 13.4% gain over the past month. The 1 year return of a 3.2% decline shows the ride has not been smooth, which...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Pharmaceutical (BMRN) Margin Compression Challenges Bullish Earnings Narratives

BioMarin Pharmaceutical (BMRN) opened 2026 with Q1 results that build on a run of quarterly revenue between US$745.1 million and US$874.6 million over 2025, while EPS has swung from a profit of US$1.25 in Q2 2025 to a loss of US$0.24 in Q4 2025 as one off items fed into the reported figures. Over the last six reported quarters, revenue has ranged from about US$745.1 million to US$874.6 million and trailing 12 month EPS has moved between US$1.70 and US$3.44. This gives you a clear view of how...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Q1 Loss Widening To US$64.5 Million Tests Profitability Narratives

Axsome Therapeutics (AXSM) Q1 2026 earnings snapshot Axsome Therapeutics (AXSM) has opened 2026 with Q1 revenue of US$191.2 million and a basic EPS loss of US$1.26, alongside a net loss of US$64.5 million, setting a clear benchmark for how the rest of the year might look. The company has seen revenue progress from US$118.8 million in Q4 2024 to US$191.2 million in Q1 2026, while trailing twelve month EPS has moved from a loss of US$5.99 to a loss of US$3.74 as revenue reached US$708.2 million...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Is Match Group (MTCH) Pricing Look Attractive After Recent Share Price Rebound

Wondering if Match Group at around US$37.65 is offering value or just noise? This article breaks down what the current price might be implying about the stock. The stock has returned 1.7% over the last 7 days, 19.8% over the last 30 days, 18.6% year to date and 28.7% over the last year, while the 5 year return sits at a 73.4% decline. These moves come as investors continue to reassess online dating platforms and subscription based business models. Match Group is often in focus during broader...
NasdaqGM:PMTS
NasdaqGM:PMTSTech

CPI Card Group (PMTS) Margin Compression Challenges Bullish Narratives Ahead Of Q1 2026

Q1 2026 earnings snapshot for CPI Card Group (PMTS) CPI Card Group (PMTS) has opened Q1 2026 earnings season with investors focused on how its recent revenue base of about US$543.5 million and trailing EPS of roughly US$1.32 over the last reported twelve months frame the story after a period of softer profitability. Over the past year, the company has seen revenue progress from US$480.6 million in 2024 Q4 to US$543.5 million in 2025 Q4, while quarterly EPS has moved between US$0.05 and...
NasdaqGS:AVNW
NasdaqGS:AVNWCommunications

Aviat Networks (AVNW) Profitability Rebound Reinforces Bullish Turnaround Narrative

Aviat Networks (AVNW) has just put out its Q3 2026 scorecard, reporting Q2 fiscal 2026 revenue of US$111.5 million and basic EPS of US$0.44 on net income of US$5.7 million. Over the last few quarters, revenue has ranged from US$88.4 million to US$118.2 million, while quarterly basic EPS has swung from a loss of US$0.94 to a profit of US$0.44. On a trailing twelve month basis, EPS is US$1.15 on net income of US$14.6 million from US$446.8 million in revenue. For investors, this mix of higher...